Atai Life Sciences N.V. (ATAI) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Discover latest Atai Life Sciences N.V. (ATAI) short-term stock forecast for year 2025, month by month, and long-term ATAI price prediction for years 2025 to 2050. Check ATAI historical stock performance, analyst ratings (Buy, Sell, or Hold), and stay updated with the latest ATAI news and headlines.
1 Month Prediction
$3.57 [52.48%]
3 Month Prediction
$3.15 [34.65%]
6 Month Prediction
$2.83 [20.96%]
1 Year Prediction
$3.42 [46.32%]
3 Year Prediction
$3.20 [36.63%]
5 Year Prediction
$2.97 [26.86%]
About Atai Life Sciences N.V.
Atai Life Sciences N.V. is a clinical-stage biopharmaceutical company that focuses on developing treatments for mental health disorders. These include psychedelic compounds and digital therapeutics. Atai was founded in 2018 and is based in Berlin, Germany, with offices in New York, USA.
Key programs in Atai's portfolio are:
- PCN-101 (R-ketamine): A subcutaneous formulation for treatment-resistant depression.
- RL-007: A modulator targeting cognitive impairment associated with schizophrenia.
- DMX-1002 (ibogaine): An oral formulation for opioid use disorder.
- GRX-917: A deuterated version of etifoxine for generalized anxiety disorder.
- VLS-01 (DMT): A formulation targeting treatment-resistant depression.
Atai Life Sciences N.V. (ATAI) Historical Performance
IPO Date
Atai Life Sciences N.V. (NASDAQ:ATAI) went public on 18 June, 2021.
Change
Since inception, ATAI has fallen from $15.50 to $2.34, a massive -84.9% decrease since 2021.
Historical Highs and Lows
In the past 4 years, the stock reached a high of $16.38 and a low of $1.04.
52 Week Range
$1.03
$2.85
The current price $2.34 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
ATAI Stock Price History
Based on ATAI stock's historical price data, this table shows how the stock has performed in the last 4 years. Since 2021, the ATAI stock has fallen from $2.66 - $5.74 to $1.55 - $2.34, which is down -85.43%. Currently, the stock follows downward trend.
Here, we have calculated stock range of ATAI, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2022 | $2.66 - $5.74 | $4.07 | -69.43 | 1 Year Change |
| 2023 | $1.04 - $2.09 | $1.61 | -87.91 | 2 Year Change |
| 2024 | $1.06 - $1.98 | $1.56 | -88.28 | 3 Year Change |
| 2025 | $1.55 - $2.34 | $1.94 | -85.43 | 4 Year Change |
ATAI Price Performance
6-Month Performance
ATAI stock jumped by 101.72% in the last six months.
1-Year Performance
The stock has trended upwards by 18.78% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 54.03%.
According to Atai Life Sciences N.V.'s historical data, below graph gives us the exact picture of how the ATAI stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 0 year and a decline in 3 years.
2022
65.14% ↓
2023
46.99% ↓
2024
5.67% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Atai Life Sciences N.V. (ATAI) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $40.00 T (Q3)
Revenue for Q3 ending 30th September, 2024 decreased 85.35% compared to Q2 ending 30th June, 2024.
Annual Revenue: $331.00 T (1Y)
Revenue for trailing 12 months increased 5.41% year over year from 31st December, 2023.
If compared to the last 5 years, the revenue has gone up from $0.00 to $331.00 thousand, a 33,099,999,900.00% change.
Market Capitalization
Atai Life Sciences N.V. has a market capitalization of $392.66M, which places ATAI in the small-cap category.
Fundamental Analysis
EPS: $-0.16 (Q3), $-0.25 (1Y)
EPS decreased 55.56% since last quarter, and decreased 74.49% since last year.
Net Income: $-26.29 M (Q3), $-40.22 M (1Y)
Net Income decreased 54.14% since last quarter, and decreased 73.60% since last year.
Free Cash Flow: $-19.34 M (Q3), $-84.71 M (1Y)
Free Cash Flow increased 19.19% since last quarter, and decreased 19.70% since last year.
Net Profit Margin: -65715.00% (Q3), -12152.27% (1Y)
Net Profit Margin increased 213.03% since last quarter, and decreased 74.96% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for ATAI stock. These indicators help you understand Atai Life Sciences N.V.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for ATAI stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $1.70 |
| SMA50 | $1.57 |
| SMA200 | $1.45 |
| RSI | 72.34 |
| Beta |
SMA20 < Current Price
This signals ATAI stock is in short-term bullish momentum.
SMA50 < Current Price
This signals ATAI stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals ATAI stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for ATAI stock is Bullish. Out of all indicators, 5 indicates bullish signals, 3 signals bearish trends and 1 gives neutral trends. The ATAI stock forecast was last updated on 11 February, 2025.
Atai Life Sciences N.V. (ATAI) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $2.84 by the end of 2025, and can reach around $3.46 to $2.73 in 2026. And, the long-term forecast suggests that the stock may further jump to $3.59 - $2.56 in 2028, and $3.20 - $3.41 by 2031. So, the ATAI stock shows a strong upward trend in the next several years.
Short-term ATAI Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-03 | $3.57 | 52.56% |
| 2025-04 | $3.59 | 53.42% |
| 2025-05 | $3.15 | 34.62% |
| 2025-06 | $2.88 | 23.08% |
| 2025-07 | $3.10 | 32.48% |
| 2025-08 | $2.83 | 20.94% |
| 2025-09 | $2.73 | 16.67% |
| 2025-10 | $2.65 | 13.25% |
| 2025-11 | $2.46 | 5.13% |
| 2025-12 | $2.84 | 21.37% |
In 2025, the ATAI stock price is expected to fluctuate between $2.46 and $3.59. According to the monthly forecast, the stock could rise to $2.84 by December 2024. If compared to the ATAI's current price, the stock could gain 21.37% by the end of this year.
Long-term ATAI Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $3.46 | $1.82 | $2.73 | 16.67% |
| 2027 | $3.47 | $1.46 | $2.94 | 25.64% |
| 2028 | $3.59 | $2.02 | $2.56 | 9.4% |
| 2029 | $3.29 | $1.93 | $3.18 | 35.9% |
| 2030 | $3.30 | $2.88 | $3.14 | 34.19% |
| 2031 | $3.20 | $1.68 | $3.41 | 45.73% |
| 2032 | $2.60 | $1.50 | $2.86 | 22.22% |
| 2033 | $2.93 | $1.87 | $3.19 | 36.32% |
| 2034 | $3.17 | $1.68 | $3.48 | 48.72% |
| 2035 | $1.86 | $1.80 | $2.46 | 5.13% |
| 2036 | $1.67 | $1.25 | $1.91 | -18.38% |
| 2037 | $1.85 | $1.19 | $2.33 | -0.43% |
| 2038 | $1.69 | $1.33 | $1.53 | -34.62% |
| 2039 | $1.17 | $1.08 | $2.43 | 3.85% |
| 2040 | $1.48 | $0.92 | $1.72 | -26.5% |
| 2041 | $1.56 | $1.31 | $1.67 | -28.63% |
| 2042 | $1.27 | $0.92 | $1.61 | -31.2% |
| 2043 | $1.38 | $1.34 | $1.21 | -48.29% |
| 2044 | $1.04 | $0.87 | $1.84 | -21.37% |
| 2045 | $0.97 | $0.91 | $1.41 | -39.74% |
| 2046 | $0.98 | $1.54 | $1.30 | -44.44% |
| 2047 | $1.26 | $0.94 | $0.60 | -74.36% |
| 2048 | $0.72 | $0.94 | $1.08 | -53.85% |
| 2049 | $1.13 | $0.85 | $1.22 | -47.86% |
| 2050 | $0.69 | $1.26 | $0.99 | -57.69% |
| 2051 | $1.13 | $1.51 | $1.14 | -51.28% |
Atai Life Sciences N.V. (ATAI) Stock Price Prediction & Forecast 2025
At the start of 2025, the ATAI stock was at $1.55. Today, it is trading at $2.34, which is 50.97% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $2.84 by December 2025 with a 21.37% change.
Atai Life Sciences N.V. (ATAI) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the ATAI stock. During this period, the ATAI's price is forecasted to shift from $3.46 to $3.14, which is -9.25% loss.
In 2026, the stock would possibly open at $3.46, descends to $1.82 by mid-year, and wraps up at $2.73, reflecting a 16.50% increase from today's price. Further moving to 2030, the stock can kick off the year at $3.30, drop to $2.88 by mid-year, and finish at $3.14, which is 34.22% change from current price.
Atai Life Sciences N.V. (ATAI) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $3.20 to $1.72, which is down 45.69%
In 2031, we can expect ATAI to fluctuate between $3.20 and $3.41, a shift indicating a 45.69% gain by year-end compared to current price. And Until 2040, ATAI can likely vary from $1.48 to $1.72. By the end of 2040, the stock could record a -26.33% fall from today's stock price.
Atai Life Sciences N.V. (ATAI) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the ATAI stock can see an a downturn from $1.56 to $0.99 in this period. In 2041, the stock can experience a low of $1.31 by mid-year, closing the year at $1.67. This results in a -43.94% decrease from today.
Moving towards the end of 2050, ATAI is projected to open the year at $0.69. The stock may peak to $1.26 during mid-year and finish the year at $0.99. Compared to the stock's current price, this translates to an overall loss of -57.72% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
ATAI Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| PLRX | Pliant Therapeutics, Inc. | - | $2.92 | -72.84% ▼ | $559.97 ▲ |
| TNXP | Tonix Pharmaceuticals Holding Corp. | - | $0.38 | 16.09% ▲ | $161.03 ▲ |
| OCGN | Ocugen, Inc. | - | $0.78 | -3.11% ▼ | $275.15 ▲ |
| MRNA | Moderna, Inc. | - | $42.25 | 1.61% ▲ | $304.87 ▲ |
| IPA | ImmunoPrecise Antibodies Ltd. | - | $0.48 | 2.92% ▲ | $108.94 ▲ |
Last updated Feb 11 at 1:26 PM
ATAI : Buy, Sell Or Hold?
Analyst Ratings
Based on 5 analysts, 1 rated as a strong buy, 4 recommended a buy, 0 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.So, according to analyst ratings, the recommendation for ATAI stock is Buy.
Expert Analysis
According to ATAI short-term and long-term forecast, Atai Life Sciences N.V. shares are projected to go down by 57.69%, and reach a value of $0.99 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 71.42857142857143, which signals Greed. Also, ATAI has recorded 12/30 green days, which reflects a 60.0% positivity rate with a price volatility of 0.08%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that ATAI stock is undervalued. So, Based on ATAI prediction and analysis, it may be the best time to buy ATAI stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "ATAI” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.